Biosceptre International Limited Alternatives & Competitors

12 companies similar to Biosceptre International Limited — Pioneering the development of a multi-targeted universal CAR-T system incorporat...

Enlaza Therapeutics

Pioneering Covalent Biologics

68 Unknown $161.00M

San Diego, United States

Biopharma Biotechnology +2

Incyclix Bio

Regaining Cell Cycle Control

13 Series B $64.00M

Durham, United States

Biotechnology Health Care +2

EpiBiologics

Next Generation Protein Degradation

50 Series B $180.00M

San Mateo, United States

Biotechnology Pharmaceutical

Sutro Biopharma, Inc.

Changing the future of Oncology

208 IPO $745.90M

South San Francisco, Unit...

Biotechnology Information Technology

Track all Biosceptre International Limited competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Harbinger Health

Pioneering the detection of early cancer.

65 Series B $190.00M

Cambridge, United States

PhoreMost Ltd

Drugging the Undruggable®

33 Series B $63.80M

United Kingdom

Biopharma Biotechnology +1

TORL BioTherapeutics LLC

Advancing novel antibody-based therapies to transform the lives of cancer patients.

61 Series C $412.00M

Culver City, United State...

Duke Street Bio

Pioneering Next Generation Cancer Therapies

10 Unknown $5.11M

London, United Kingdom

Mercurial AI

Empowering providers and patients to overcome cancer with AI copilots

5 Seed $220.00K

Chicago, United States

Gensun Biopharma

We are dedicated to the discovery and development of innovative biological therapeutics fo...

United States

Biopharma Biotechnology +2

Adcytherix

Building an ADC Powerhouse

24 Series A $135.00M

Marseille, France

OncoResponse

Interrogating for Cures

10 Unknown $117.10M

Houston, United States

Biopharma Biotechnology +2

About Biosceptre International Limited

Pioneering the development of a multi-targeted universal CAR-T system incorporating our nfP2X7 technology

Services

Development of multi-targeted universal CAR T systems, Innovative cancer therapy research, Combination of CAR T with targeted antibodies, Oncology treatment advancements

Target Customers

Cancer patients, Healthcare providers, Oncology specialists, Biopharmaceutical investors

Taxonomy

CAR-T Therapy, Cancer Treatment, Multi-targeted Therapy, Universal CAR-T System, NfP2X7 Technology, Cell Therapy, Cancer Innovation, Therapeutic Advancements, Oncology, Malignancy Treatment, Cancer Patient Care

Business Model

B2B, B2D, B2B2C

Revenue Model

Licensing, Product Sales, Service Fee

Frequently Asked Questions

Top alternatives to Biosceptre International Limited include Enlaza Therapeutics, Incyclix Bio, EpiBiologics, Sutro Biopharma, Inc., Harbinger Health. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Biosceptre International Limited based on industry overlap, target customers, and business model.

Pioneering the development of a multi-targeted universal CAR-T system incorporating our nfP2X7 technology

Don't just read about them. Follow them.

BounceWatch watches Biosceptre International Limited and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Biosceptre International Limited Profile Enlaza Therapeutics Alternatives Incyclix Bio Alternatives EpiBiologics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Biosceptre International Limited on 11 Mar 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.